Ethical considerations of the dynamics of clinical trials in an epidemic context: Studies on COVID-19

December 16, 2020

Bahans, C., Leymarie, S., Malauzat, D., Girard, M., & Demiot, C.

Ethics, Medicine and Public Health

The adaptability of any systematic strategy to new contexts, particularly in crisis times, will be a crucial part of its success. This article, however, discusses how principles such as those established in the Declaration of Helsinki should be restructured only to a certain extent, and any adjustments should be absolutely monitored and analyzed. This pandemic made bureaucratic investigation processes ten times faster than ever before, which ethical investigation committees (CIEs) have perceived with many methodological deficiencies. The authors also underline the role that the media have played during the first wave of contagion and recognize the importance of the general public's opinion and its relation to the possibility of allowing or stopping clinical research. COVID-19 has brought the CIEs the opportunity to reinforce their vital importance within the scientific research processes and simultaneously has opened the door for new questions and alternatives about the present avenues of ethical examination of projects in science

Bahans C, Leymarie S, Malauzat D, Girard M, Demiot C. Ethical considerations of the dynamics of clinical trials in an epidemic context: Studies on COVID-19. Ethics Med Public Health. 2021;16:100621. doi:10.1016/j.jemep.2020.100621

Partners